The global Cell Surface Markers Detection Market Growth Accelerated by Increasing Application of Cell Surface Markers.


Cell surface markers are used to identify and study cell types and immune cell cancers which has increased application in research for drug discovery and disease diagnostics. Cell surface markers play a crucial role in understanding cell signaling, communication and interactions which helps diagnose diseases like cancer at an early stage. Products associated with the cell surface markers detection market include instruments, reagents & kits used for flow cytometry, immunohistochemistry (IHC) and other applications.

The global Cell Surface Markers Detection Market is estimated to be valued at US$ 5,459.5 Mn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increasing application of cell surface markers is one of the key trends driving the growth of this market. Researchers and medical professionals are increasingly using cell surface markers for understanding physiological and pathological conditions at a molecular level. Cell surface markers help in profiling cell types which is useful in stem cell research, immunology and developing novel targeted disease therapies. This has resulted in rising funding for cell surface research from government and private organizations. With continuous advancements in detection technologies like flow cytometry, the application of cell surface markers is expected to grow significantly over the forecast period.

Segment Analysis
The global cell surface markers detection market is dominated by the flow cytometry segment which holds around 55% of the market share. Flow cytometry is considered to be the gold standard technique for cell surface marker detection due to its high sensitivity and the ability to analyze multiple parameters simultaneously. It enables detection, counting, and characterization of cells based on their physical and chemical properties. Due to the benefits of flow cytometry over other techniques, it is widely used in disease diagnosis, treatment response analysis, understanding disease mechanisms, and for research applications in various disease areas such as cancer, HIV/AIDS, and autoimmune diseases.

Key Takeaways
The global cell surface markers detection market is expected to witness high growth over the forecast period of 2023 to 2030. The global Cell Surface Markers Detection Market is estimated to be valued at US$ 5,459.5 Mn in 2023 and is expected to exhibit a CAGR of 9.1% over the forecast period 2023 to 2030.

Regional analysis
North America dominated the global market and accounted for around 40% share in 2023 owing to the rising prevalence of chronic diseases, growing R&D investments, and presence of leading market players in the region. Asia Pacific is expected to grow at the fastest pace during the forecast period driven by increasing healthcare expenditure, rising awareness about advanced disease diagnostic techniques, and growing research activities in countries such as China and India.

Key players
Key players operating in the cell surface markers detection market are Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD), Qiagen NV, Diasorin SpA (Luminex Corporation), and Danaher Corporation (Beckman Coulter Inc.).

Get more insights on this topic:

Cell therapy Manufacturing Market

Platelet RIch Plasma Market


Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more